Blocking a hunger hormone receptor makes aging muscles stronger
As people age, they steadily lose muscle mass — and a hormone best known for triggering hunger may be making things worse.
Ghrelin is typically called the ‘hunger hormone’: it rises before meals, falls after eating, and signals the brain that it’s time to eat. But as animals age, baseline ghrelin levels climb persistently — and this appears to take a toll on muscle function. Researchers writing in Aging Cell describe how suppressing the ghrelin receptor in older mice leads to noticeably stronger muscles, better mitochondrial performance, and reduced signs of sarcopenia. Sarcopenia — the age-related loss of muscle mass and strength — is one of the leading reasons older adults lose their independence.
What ghrelin does as you age
This work builds on earlier findings showing that fully deleting the ghrelin gene in mice restores mitochondrial function and muscle strength. Mitochondria are the cell’s energy generators, and their declining efficiency is considered one of the central mechanisms of aging. Cells that produce energy less effectively function poorly and die sooner — and in muscle tissue, this degradation is especially visible.
The new experiments targeted not the hormone itself but its receptor: the molecular lock that ghrelin binds to activate its effects. Blocking that receptor — rather than eliminating the hormone entirely — opens a more pharmacologically promising avenue. Receptors are generally easier to target with drugs than hormones are to neutralize. Older mice with suppressed ghrelin receptors showed clearly better muscle function than age-matched controls.
From mouse to human: how big is the leap?
Ghrelin receptor blockers already exist as experimental compounds, studied mainly in the context of obesity and metabolic disorders. The question now is whether the same approach could slow age-related muscle loss in people. That’s not a small question: sarcopenia affects an estimated ten to fifteen percent of people over sixty, and is linked to higher risks of falls, hospitalization, and premature death.
Still, caution is warranted. Ghrelin does many things at once — it influences not only appetite and muscle, but also sleep, mood, and growth hormone release. Long-term receptor blockade could have unintended effects that short-term mouse studies simply don’t capture. Clinical trials in humans are the only way to find out — and none have started yet.